109 related articles for article (PubMed ID: 22422660)
1. Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARĪ³ independent manner.
Zhong ZF; Li YB; Wang SP; Tan W; Chen XP; Chen MW; Wang YT
J Cell Biochem; 2012 Aug; 113(8):2643-51. PubMed ID: 22422660
[TBL] [Abstract][Full Text] [Related]
2. Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo.
Zhong Z; Dang Y; Yuan X; Guo W; Li Y; Tan W; Cui J; Lu J; Zhang Q; Chen X; Wang Y
Cell Physiol Biochem; 2012; 30(3):778-90. PubMed ID: 22854281
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
4. Furanodiene enhances the anti-cancer effects of doxorubicin on ERĪ±-negative breast cancer cells in vitro.
Zhong ZF; Qiang WA; Wang CM; Tan W; Wang YT
Eur J Pharmacol; 2016 Mar; 774():10-9. PubMed ID: 26607462
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by furanodiene in HL60 leukemia cells through activation of TNFR1 signaling pathway.
Ma E; Wang X; Li Y; Sun X; Tai W; Li T; Guo T
Cancer Lett; 2008 Nov; 271(1):158-66. PubMed ID: 18667267
[TBL] [Abstract][Full Text] [Related]
6. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells.
Yu HN; Noh EM; Lee YR; Roh SG; Song EK; Han MK; Lee YC; Shim IK; Lee SJ; Jung SH; Kim JS; Youn HJ
Biochem Biophys Res Commun; 2008 Dec; 377(1):242-7. PubMed ID: 18835379
[TBL] [Abstract][Full Text] [Related]
9. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner.
Zhong ZF; Tan W; Qiang WW; Scofield VL; Tian K; Wang CM; Qiang WA; Wang YT
Mol Biosyst; 2016 Apr; 12(5):1626-37. PubMed ID: 26987443
[TBL] [Abstract][Full Text] [Related]
10. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
Lee TH; Chuang LY; Hung WC
Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
[TBL] [Abstract][Full Text] [Related]
13. Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro.
Zhong Z; Tan W; Chen X; Wang Y
Eur J Pharmacol; 2014 Aug; 737():1-10. PubMed ID: 24824922
[TBL] [Abstract][Full Text] [Related]
14. Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells.
Cover CM; Hsieh SJ; Cram EJ; Hong C; Riby JE; Bjeldanes LF; Firestone GL
Cancer Res; 1999 Mar; 59(6):1244-51. PubMed ID: 10096555
[TBL] [Abstract][Full Text] [Related]
15. All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor beta to stimulate apoptosis in MCF-7 breast cancer cells.
Danforth DN
J Endocrinol; 2004 Nov; 183(2):395-404. PubMed ID: 15531727
[TBL] [Abstract][Full Text] [Related]
16. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
Mandlekar S; Yu R; Tan TH; Kong AN
Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
[TBL] [Abstract][Full Text] [Related]
17. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway.
Patil JB; Kim J; Jayaprakasha GK
Eur J Pharmacol; 2010 Oct; 645(1-3):70-8. PubMed ID: 20691179
[TBL] [Abstract][Full Text] [Related]
18. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
Berstein LM; Yue W; Wang JP; Santen RJ
Breast Cancer Res Treat; 2011 Jul; 128(1):109-17. PubMed ID: 20683653
[TBL] [Abstract][Full Text] [Related]
19. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
[TBL] [Abstract][Full Text] [Related]
20. Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathways.
Shyur LF; Lee SH; Chang ST; Lo CP; Kuo YH; Wang SY
Phytomedicine; 2010 Dec; 18(1):16-24. PubMed ID: 20637573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
